Elizabeth D. Barnett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elizabeth D. Barnett has a total of 338 co-authors. Here are the top co-authors by number of shared publications:
- Davidson H. Hamer
Department of Global Health, Boston University School of Public Health, Boston, MA, USA
11 shared publications Mary E. Wilson
Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
11 shared publications- Lin Hwei Chen
Division of Infectious Diseases, Department of Medicine, Mount Auburn Hospital , Cambridge, Massachusetts
10 shared publications - Francesco Castelli
Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy
8 shared publications Jerome O. Klein
8 shared publications- Annelies Wilder-Smith
World Health Organization, Headquarters, Geneva, Switzerland
7 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 68, 102911
Ready for takeoff? exploring United States health care providers’ pretravel consultation priorities, gaps, barriers, and opportunities
- 1 October 2025
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 68, 102911
Open AccessReady for takeoff? exploring United States health care providers’ pretravel consultation priorities, gaps, barriers, and opportunities
- Open Access
- 8 January 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (1) , 226-233
Core Content, Competencies, and Accreditation in US Global Health Fellowships: A Survey of Leaders’ Perspectives
: The number of global health (GH) fellowships in the United States has increased over the past two decades. However, there are currently no standard requirements, shared core content, or widespread systems of accreditation. With the growth in programs, it is appropriate to consider these issues. We conducted a national survey to understand GH fellowship leaders’ perspectives on the existence of core content and competencies and on the need for accreditation, including by the Accreditation Council of Graduate Medical Education (ACGME). We sent survey invitations to 123 fellowship leaders. Forty-five completed the survey (37%), representing seven specialties. Eighty-nine percent of respondents indicated that there is important core content for fellows to learn regardless of specialty; 30% indicated that accreditation would be “very” or “extremely” beneficial, whereas 21% indicated that it would be “not at all” beneficial. When asked what form of accreditation would result in training the most competent GH practitioners, 35% indicated that accreditation is unnecessary. Of those selecting a form of accreditation, the largest proportion (21%) selected accreditation from a professional society; 52% “disagreed” or “strongly disagreed” that ACGME accreditation is needed. More than 65% indicated that loss of training flexibility, funding restrictions, and increased administrative and fellow funding burdens are “very” or “extremely” important barriers. These results suggest that broad agreement on important core content exists across specialties, with a lack of consensus about the need for accreditation. More discussion with stakeholders, including international partners, is needed to understand their perceptions and build consensus before pursuing fellowship accreditation.
- 8 January 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (1) , 226-233
Open AccessCore Content, Competencies, and Accreditation in US Global Health Fellowships: A Survey of Leaders’ Perspectives
: The number of global health (GH) fellowships in the United States has increased over the past two decades. However, there are currently no standard requirements, shared core content, or widespread systems of accreditation. With the growth in programs, it is appropriate to consider these issues. We conducted a national survey to understand GH fellowship leaders’ perspectives on the existence of core content and competencies and on the need for accreditation, including by the Accreditation Council of Graduate Medical Education (ACGME). We sent survey invitations to 123 fellowship leaders. Forty-five completed the survey (37%), representing seven specialties. Eighty-nine percent of respondents indicated that there is important core content for fellows to learn regardless of specialty; 30% indicated that accreditation would be “very” or “extremely” beneficial, whereas 21% indicated that it would be “not at all” beneficial. When asked what form of accreditation would result in training the most competent GH practitioners, 35% indicated that accreditation is unnecessary. Of those selecting a form of accreditation, the largest proportion (21%) selected accreditation from a professional society; 52% “disagreed” or “strongly disagreed” that ACGME accreditation is needed. More than 65% indicated that loss of training flexibility, funding restrictions, and increased administrative and fellow funding burdens are “very” or “extremely” important barriers. These results suggest that broad agreement on important core content exists across specialties, with a lack of consensus about the need for accreditation. More discussion with stakeholders, including international partners, is needed to understand their perceptions and build consensus before pursuing fellowship accreditation.
- 29 January 2023
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 156, 103821
Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy in comparison with unvaccinated controls
- 29 January 2023
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 156, 103821
Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy in comparison with unvaccinated controls
- 15 May 2021
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (6) , e420-e423
Multisystem Inflammatory Syndrome in an Adult With COVID-19—A Trial of Anakinra
COVID-19 disease has been a pandemic caused by a β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A life-threatening multisystem inflammatory syndrome (MIS), secondary to SARS-CoV-2 virus infection, sharing common features with Kawasaki disease shock syndrome, staphylococcal/streptococcal shock syndrome, and macrophage activation syndrome in pediatric patients has been described. A total of 27 cases in adults (MIS-A) with a similar presentation have been reported so far. Here we describe the case of a 21-year-old man admitted with abdominal pain, diarrhea, tachycardia, and low blood pressure. He had elevated troponin, ferritin, and interleukin-2 receptor levels and had evidence of myocarditis. He tested positive for SARS-CoV-2 IgG antibody, and a diagnosis of MIS-A was made. Our case adds to the scant literature on this topic, and to our knowledge, it is the first case where anakinra was administered. He recovered well. MIS-A should be considered when young adults present with multiorgan dysfunction.
- 15 May 2021
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (6) , e420-e423
Multisystem Inflammatory Syndrome in an Adult With COVID-19—A Trial of Anakinra
COVID-19 disease has been a pandemic caused by a β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A life-threatening multisystem inflammatory syndrome (MIS), secondary to SARS-CoV-2 virus infection, sharing common features with Kawasaki disease shock syndrome, staphylococcal/streptococcal shock syndrome, and macrophage activation syndrome in pediatric patients has been described. A total of 27 cases in adults (MIS-A) with a similar presentation have been reported so far. Here we describe the case of a 21-year-old man admitted with abdominal pain, diarrhea, tachycardia, and low blood pressure. He had elevated troponin, ferritin, and interleukin-2 receptor levels and had evidence of myocarditis. He tested positive for SARS-CoV-2 IgG antibody, and a diagnosis of MIS-A was made. Our case adds to the scant literature on this topic, and to our knowledge, it is the first case where anakinra was administered. He recovered well. MIS-A should be considered when young adults present with multiorgan dysfunction.
- 1 November 2019
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 32, 101504
International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study
- 1 November 2019
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 32, 101504
International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study
- Open Access
- 20 June 2019
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 26 (6)
The rise in travel-associated measles infections—GeoSentinel, 2015–2019
Measles remains a global threat to human health. In 2018, the World Health Organization (WHO) reported over 328 000 measles cases among 184 WHO member states, with the European Region reporting the most cases (25.6%). 1 From January to March 2019, reported cases rose 300% in comparison to the same months in 2018. 2 Low vaccination coverage for measles is presumed to be responsible for this recent increase. 3–5 International travelers to measles-affected countries are at risk for infection and may contribute to disease importation. 3, 4
- 20 June 2019
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 26 (6)
Open AccessThe rise in travel-associated measles infections—GeoSentinel, 2015–2019
Measles remains a global threat to human health. In 2018, the World Health Organization (WHO) reported over 328 000 measles cases among 184 WHO member states, with the European Region reporting the most cases (25.6%). 1 From January to March 2019, reported cases rose 300% in comparison to the same months in 2018. 2 Low vaccination coverage for measles is presumed to be responsible for this recent increase. 3–5 International travelers to measles-affected countries are at risk for infection and may contribute to disease importation. 3, 4
- 1 January 2018
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 25 (1)
Screening migrants and travellers for latent tuberculosis: what is new?
- 1 January 2018
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 25 (1)
Screening migrants and travellers for latent tuberculosis: what is new?
- 5 April 2017
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 96 (4) , 929-934
Seroprevalence of Hepatitis E Among Boston Area Travelers, 2009–2010
We determined the prevalence of IgG antibodies to hepatitis E virus (anti-HEV IgG) among travelers attending Boston-area travel health clinics from 2009 to 2010. Pre-travel samples were available for 1,356 travelers, with paired pre- and post-travel samples for 450 (33%). Eighty of 1,356 (6%) pre-travel samples were positive for anti-HEV IgG. Compared with participants who had never lived in nor traveled to a highly endemic country, the pre-travel prevalence odds ratio (POR) of anti-HEV IgG among participants born in or with a history of previous travel to a highly endemic country was increased (POR = 4.8, 95% CI = 2.3–10.3 and POR = 2.6, 95% CI = 1.4–5.0, respectively). Among participants with previous travel to a highly endemic country, anti-HEV IgG was associated with age > 40 years (POR = 3.7, 95% CI = 1.3–10.2) and travel history to ≥ 3 highly endemic countries (POR = 2.7, 95% CI = 1.2–5.9). Two participants may have contracted HEV infection during their 2009–2010 trip.
- 5 April 2017
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 96 (4) , 929-934
Seroprevalence of Hepatitis E Among Boston Area Travelers, 2009–2010
We determined the prevalence of IgG antibodies to hepatitis E virus (anti-HEV IgG) among travelers attending Boston-area travel health clinics from 2009 to 2010. Pre-travel samples were available for 1,356 travelers, with paired pre- and post-travel samples for 450 (33%). Eighty of 1,356 (6%) pre-travel samples were positive for anti-HEV IgG. Compared with participants who had never lived in nor traveled to a highly endemic country, the pre-travel prevalence odds ratio (POR) of anti-HEV IgG among participants born in or with a history of previous travel to a highly endemic country was increased (POR = 4.8, 95% CI = 2.3–10.3 and POR = 2.6, 95% CI = 1.4–5.0, respectively). Among participants with previous travel to a highly endemic country, anti-HEV IgG was associated with age > 40 years (POR = 3.7, 95% CI = 1.3–10.2) and travel history to ≥ 3 highly endemic countries (POR = 2.7, 95% CI = 1.2–5.9). Two participants may have contracted HEV infection during their 2009–2010 trip.